Mining Natural Immunity: Discovery of Malaria-Protective Antibodies
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
August 2025
June 2025
Anti-Idiotype: Test Then Express – Functional Pre-Selection Accelerates Antibody Discovery
In this webinar, you will learn: How to efficiently filter out non-specific binders early on to focus only on antibodies with true functional potential. Strategies to isolate highly specific anti-idiotype antibodies that avoid cross-reactivity with natural IgGs. The benefits of combining advanced enrichment techniques with proteomics to discover both blocking (type 1) [...]
May 2025
Functional Enrichment Strategies for Anti-Idiotypic Antibody Discovery
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
April 2025
Anti-Idiotypic Antibodies in Drug Development
Written by: Genya Gorshtein, MSc Published: April 9, 2025 Contents Introduction What Is An Anti-Idiotypic Antibody? Applications of Anti-Idiotypic Antibodies in Drug Development Discovery and Generation of Anti-Idiotypic Antibodies Anti-Idiotype Antibody Discovery with Rapid Novor Introduction Anti-idiotypic antibodies are specialized antibodies that bind to [...]
July 2024
Antibody Discovery in Humans – Starting with Functional, Circulating Antibodies
This paper is now published in Nature Communications! Le Bihan, T., Nunez de Villavicencio Diaz, T., Reitzel, C. et al. De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination. Nat Commun 15, 8790 (2024). https://doi.org/10.1038/s41467-024-53105-8 In this webinar, you will: Explore how using a [...]